Over the past month, CL has declined by 6.3%, and year-to-date, it’s down 14.24%. The 52-week range is $77.09 to $102.61, indicating the stock is near its yearly low.
Key Financials:
Market Cap: $63.01 billion
Revenue (TTM): $20.00 billion
Net Income (TTM): $2.91 billion
EPS (TTM): $3.56
P/E Ratio: 21.90
Forward P/E: 20.76
Dividend Yield: 2.67% ($2.08 annually, ex-dividend date Oct 17, 2025)
Beta: 0.34 (low volatility)
Analyst Outlook: Analysts rate CL as a "Moderate Buy" with a consensus price target of $93.50, suggesting a potential upside of 19.93%. Price targets range from $80 to $108. Recent analyst actions include downgrades (e.g., Wells Fargo maintaining a "Sell" rating at $80) and upgrades (e.g., Citigroup and UBS with "Strong Buy" ratings at $10
Key Financials:
Market Cap: $63.01 billion
Revenue (TTM): $20.00 billion
Net Income (TTM): $2.91 billion
EPS (TTM): $3.56
P/E Ratio: 21.90
Forward P/E: 20.76
Dividend Yield: 2.67% ($2.08 annually, ex-dividend date Oct 17, 2025)
Beta: 0.34 (low volatility)
Analyst Outlook: Analysts rate CL as a "Moderate Buy" with a consensus price target of $93.50, suggesting a potential upside of 19.93%. Price targets range from $80 to $108. Recent analyst actions include downgrades (e.g., Wells Fargo maintaining a "Sell" rating at $80) and upgrades (e.g., Citigroup and UBS with "Strong Buy" ratings at $10
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.